A monthly audio round-up detailing the contents of the latest issue of DTB.

Articles:
Uncommon knowledge DTB 2009; 47: 121
Aspirin for primary prevention of cardiovascular disease? DTB 2009; 47: 122 - 125
Over-the-counter weight loss with orlistat? DTB 2009; 47: 125 - 127
Management of seasonal affective disorder DTB 2009; 47: 128 - 132

A monthly audio round-up detailing the contents of the latest issue of DTB.

Articles:
Generically speaking DTB 2009; 47: 109
Does BNP testing aid diagnosis of heart failure? DTB 2009; 47: 110 - 113
Imiquimod for superficial and in situ skin malignancy DTB 2009; 47: 113 - 116
Anticoagulation with dabigatran or rivaroxaban DTB 2009; 47: 116 - 120

The widespread use of oseltamivir (Tamiflu) has been a key strategy in tackling the H1N1 ‘swine flu’ pandemic in the UK. However, there have been growing concerns about the communication of this approach and rationale behind the policy itself. In this podcast Dr Ike Iheanacho, DTB editor, discusses the policy with two members of the DTB editorial board, Dr Paul Caldwell, a general practitioner and Dr Mahdad Noursadeghi, an infectious diseases consultant. This is an extension of our September 2009 Editorial, Tamiflu − the wrong message? DTB 2009; 47: 97.

A monthly audio round-up detailing the contents of the latest issue of DTB.

Articles:
Tamiflu − the wrong message? DTB 2009; 47: 97
Self-monitoring for patients on warfarin? DTB 2009; 47: 98 - 101
Non-drug management of chronic low back pain DTB 2009; 47: 102 - 108
Correction: How to misinform patients DTB 2009; 47: 108

A monthly audio round-up detailing the contents of the latest issue of DTB.

Articles:
How to misinform patients DTB 2009; 47: 85
Management of carpal tunnel syndrome DTB 2009; 47: 86 - 89
So, what exactly is a cytokine? DTB 2009; 47: 89 - 91
Ezetimibe – an update DTB 2009; 47: 91 - 95
Understanding statistical terms: 5 – systematic reviews and meta-analyses DTB 2009; 47: 95 - 96

A monthly audio round-up detailing the contents of the latest issue of DTB.

Articles:
Only in England DTB 2009; 47: 73
Melatonin for primary insomnia? DTB 2009; 47: 74 - 77
Which approach for first trimester miscarriage? DTB 2009; 47: 77 - 80
What are excipients doing in medicinal products? DTB 2009; 47: 81 - 84

A monthly audio round-up detailing the contents of the latest issue of DTB.

Articles:
Real costs of end-of-life drugs DTB 2009; 47: 61
Management of benign paroxysmal positional vertigo DTB 2009; 47: 62 - 66
Interferon-gamma release assays and TB diagnosis DTB 2009; 47: 67 - 70
Understanding statistical terms: 4 – Diagnostic tests DTB 2009; 47: 71 - 72

In January 2009, NICE began a policy for valuing the use of drugs for extending life in people with a short life-expectancy. This development arose from concerns that NICE had been denying patients life-extending treatments because they were too expensive. However, the new policy also raises important ethical and moral dilemmas. In this podcast Dr Martin Duerden, General Practitioner and member of the DTB editorial board, and Dr Ike Iheanacho, DTB Editor, discuss this policy and the issues it raises. This is an extension of our June 2009 Editorial, Real costs of end-of-life drugs DTB 2009; 47: 61.

A monthly audio round-up detailing the contents of the latest issue of DTB.

Articles:
The mad world of epilepsy drugs DTB 2009; 47: 49
Update on treatments for head lice DTB 2009; 47: 50 - 52
What role for colesevelam in cardiovascular prevention? DTB 2009; 47: 53 - 5
Why look at an SPC? DTB 2009; 47: 56 - 58
Understanding statistical terms: 3 DTB 2009; 47: 59 - 60

A monthly audio round-up detailing the contents of the latest issue of DTB.

Articles:
What are you on? DTB 2009; 47: 37
Preventing recurrent venous thromboembolism. DTB 2009; 47: 38 - 41
Drospirenone in HRT? DTB 2009; 47: 41 - 4
The licensing of medicines in the UK. DTB 2009; 47: 45 – 48